In late January and early February this year, the University of Sydney ran two microsurgical courses, for the first time requiring first-year RANZCO trainees to attend. Both courses were packed with the usual corneal suturing of pigs’ eyes, EyeSi simulator time, eyelid operations on human cadavers,
The Ophthalmic Assistant: a text for allied and associated ophthalmic personnel is a comprehensive and detailed textbook and reference tool for those working in the field of ophthalmology. Written by Drs Harold Stein, Raymond Stein, Melvin Freeman and Rebecca Stein, and several other contributing
Age-related macular degeneration (AMD) is the most common cause of blindness, contributing to about 50% of all blindness in New Zealand. It is estimated that 1 in 7 people over the age of 50 will be a
The risk of uveitis due to prostaglandin analogues in paediatric glaucoma
There doesn't seem much point in bluffing it these days – the audience is a bit more limited and most of my mob know the script. It’s a shame, as I quite enjoyed the pretend years, shuffling around tentatively, wielding the cane like a staff of office and quietly enjoying muttered asides like, “It’s
The march of veganism continues to sweep more people into a cruelty-free lifestyle while shaking off the antiquated associations of dreadlocks and lentils to become the norm for the ‘urban woke’.
The war in Ukraine, volatile European markets and currencies and challenges across China’s political and economic landscape are just some of the issues impacting almost every country around the world, including New Zealand.
Geographic atrophy (GA) is the late manifestation of non-neovascular age-related macular degeneration (AMD) characterised by progressive loss of retinal pigment epithelium (RPE) and photoreceptors. Until now, it was a slowly progressive untreatable disease that led to vision loss.
After more than five years, the debate rages on between Ophthalmology New Zealand (ONZ) and Southern Cross Health Society (SCHS) over funding for minimally invasive glaucoma surgery (MIGS) devices for
Archway randomised phase 3 trial of ranibizumab port delivery system for nAMDHolekamp N et alOphthalmology, 2022. 129(3): p. 295-307
Fuchs’ endothelial corneal dystrophy (FECD) was first described in 1910 by Ernst Fuchs and is the most common posterior corneal dystrophy. FECD is a progressive dysfunction of the corneal endothelium
There is a well-understood narrative for the history of humanity. It describes how we made our way from the Stone Age to Instagram and all of those small miracles we take for granted: the computer in our pocket, the satellites we put in space, the digital clocks on our appliances that blink ‘00:00’,